Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history shows a recruitment status update indicating no longer looking for participants, and a new Revision: v3.6.0 was recorded (replacing the previous v3.5.5).SummaryDifference0.5%

- Check20 days agoChange DetectedA new revision tag v3.5.5 was added to the history. The previous tag v3.5.4 was removed from the list.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision (v3.5.4) appears in the page's revision history, indicating an update to the site's underlying content or layout. This change is a behind-the-scenes update and does not alter the study information shown.SummaryDifference0.1%

- Check63 days agoChange DetectedClinicalTrials.gov’s displayed revision version was updated from v3.5.2 to v3.5.3, indicating a site/interface version change rather than an edit to the study’s content.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision 3.5.0 has been added to the record history, and revision 3.4.3 has been removed.SummaryDifference0.1%

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.